Q&A with writing group vice chair Mina Chung, MD
NIH grant funds research into variants that raise risk
Extra caution in order for this vulnerable population
New device looks to be a vital second-line therapy for selected patients
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy